Although CCNC loss of function mutations have been reported in some patients with T-ALL 23, the involvement of membrane-bound DLL4 in cancer cells remained elusive until our present proof of concept study showing DLL4 involvement in the human disease. This evidence concerns the gene DLL4 and acute lymphoblastic leukemia.